To analyze the single nucleotide polymorphisms (SNPs) of two subtypes of neurokinin (NK) receptors, NK1R and NK2R (also known as TAC1R and TAC2R), in colorectal cancer (CRC), peripheral blood samples were collected from 199 CRC patients. Direct-sequencing was performed to identify the NK1R rs10198644 and NK2R rs4644560 SNPs. Genotype results were correlated with clinical factors. The allele frequencies of NK1R rs10198644 GC, CC and GG were 52, 17 and 31%, respectively, while that of NK2R rs4644560 GC, CC, and GG were 36, 50 and 14%, respectively. Patients with NK2R rs4644560 GC exhibited more positive lymph nodes than those with CC (mean, 2.2 vs. 1.3; P=0.016). Further analysis highlighted that the number of positive lymph nodes was also increased in the NK2R rs4644560 GC/NK1R rs10198644 GG group compared with the NK2R rs4644560 GG/NK1R rs10198644 GG group (mean, 2.2 vs. 0.9; P=0.04). These data suggested that the NK2R rs4644560 GC polymorphism alone or combination with NK1R rs10198644 GG may be a promising prognostic marker of lymph node metastasis in CRC patients.
Introduction
Neurokinins (NKs) are small neuropeptides that are present in the tumor microenvironment and can act on different stages of carcinogenesis (1) . Substance P (SP) and NK A (NKA) and B (NKB) are classical members of the NK family, which exert their biological effects by activating NK receptors denoted as NK1R, NK2R and NK3R (also known as TAC1R, TAC2R and TAC3R) (2) . SP, the endogenous ligand for NK1R, activates responses correlated with tumor growth in several human cell lines bearing NK1R receptors (3) . Moreover, NKA, the endogenous ligand for NK2R, is a good predictor of survival in patients with stage IV well-differentiated small bowel neuroendocrine neoplasms (4) . Numerous tumors that express NKRs can misuse the NK-induced signaling of normal cells to promote the proliferation and survival of cancer cells, releasing cytokines and soluble mediators that favor tumor growth (5) . However, the precise involvement and significance of NK in cancer pathologies remains to be fully defined.
NKRs belong to the family of seven transmembrane G-protein coupled receptors. NK1R and NK2R are dispersed throughout the central and peripheral nervous systems, while NK3R is distributed mainly in the central nervous system (6) . Human NK1R and NK2R are 407-and 398-amino acid proteins, respectively (7) . NK2R is expressed in a variety of organs, including the gastrointestinal tract, while functional data suggest that NK2R could be significant in mediating the NK-evoked smooth muscle contraction of organs (8) . The prevalence of the NK2R mRNA α isoform indicates that NK2R is significantly involved in regulating human colonic functions (9) .
In the United States, colorectal cancer (CRC) has the third highest incidence of new cases and the third highest rate of cancer-associated mortality, with 142,280 and 50,830 cases, respectively, in 2013 (10) . It is also estimated that the mortality rate for CRC has been gradually increasing in China (11) . The occurrence and development of this deadly disease may vary among patients; this may be attributed to variations in genotype patterns. Recently, a population-based epidemiological study in a Chinese population found that the NK2R rs4644560 genotype appeared to be associated with a decreased risk of CRC when combined with NK1R rs10198644 (12 An individual who consumed alcohol more than once per day for at least three months was considered as an alcohol drinker and an individual who had smoked more than one cigarette per day for over one year was considered as a tobacco user. Diagnostic stage was confirmed according to the National Comprehensive Cancer Network guidelines for CRC (13) . Differentiation grade was defined as poor, moderate and well. An abnormal CEA level was defined as a level of >5 ng/ml.
Genotyping. Genomic DNA was extracted from whole blood samples using the QIAamp DNA Mini kit (Qiagen GmbH, Hilden, Germany) according to the manufacturer's instructions. Genotyping was performed with polymerase chain reaction (PCR) amplification and direct-sequencing. Primers were designed with Primer Premier 5.0 software (PREMIER Biosoft, Palo Alto, CA, USA) and synthesized by Genewiz Biotech (Beijing, China). The primer sequences used for amplification were as follows: NK1R forward, 5'-AAAGTTGGGATCTGCTTACACT-3' and reverse, 5'-TTT CTTTTCTCTCACTGTCCCA-3'; and NK2R forward, 5'-ATG CTGCTGTGTCATCTGCT-3' and reverse, 5'-TATCTTGCC CAGGTTGGTCT-3'. The PCR was performed with 50 ng of genomic DNA, 0.25 µM of each primer, 200 µM of each deoxyribonucleotide, 3 mM MgCl 2 and 0.2 Units of Taq DNA polymerase (Takara, Dalian, China). The PCR amplification was performed as follows: Initial denaturation at 95˚C for 5 min, followed by 9 cycles of denaturation at 95˚C for 45 sec, annealing at 58˚C for 45 sec (decreasing by 0.2˚C every cycle) and elongation at 72˚C for 30 sec; then 34 cycles of denaturation at 95˚C for 45 sec, annealing at 55˚C for 45 sec (decreasing by 0.2˚C every cycle) and elongation at 72˚C for 30 sec; and a final elongation at 72˚C for 5 min.
The PCR products were purified using the SAP/EXO PCR kit (New England Biolabs, Inc., Ipswich, MA, USA). Two microliters of the purified amplicons were directly used for a sequencing reaction with the Big Dye Terminator cycle sequencing mix v3.1 (Applied Biosystems Life Technologies, Foster City, CA, USA). Dye purification was performed by alcohol/sodium acetate precipitation. Sequence analysis was performed on an ABI 3730xl DNA analyzer (Applied Biosystems Life Technologies). A one-way analysis of variance (ANOVA) was used to further clarify the impact of different genotype combinations of NK2R and NK1R on the number of positive lymph nodes. Prior to the analysis, the genotypes of NK2R and NK1R were first mixed into nine groups (Fig. 1) .
Results
A total of 199 patients with pathologically confirmed CRC were enrolled in the study following surgical resection. The median age of the patients was 61 years (range, 23-84 years), and the detailed patient characteristics are listed in Table I . The allele frequencies of NK1R rs10198644 GC, CC and GG were 52, 17 and 31%, respectively, while for NK2R rs4644560 GC, CC and GG, the frequencies were 36, 50 and 14%. A comprehensive analysis of all patient factors, including demographic, lifestyle and clinical factors, was performed in order to clarify their association with the genotypes of NK1R and NK2R, as well as the interaction between them. The positive outcomes are described below. In total, there were 191 patients for whom information regarding positive lymph node numbers and tobacco exposure was available. Among these patients, 53 were in the tobacco group and 138 were in the non-tobacco group, and the mean number of positive lymph nodes was 3.2 and 2.0, respectively. The t-test showed that the tobacco group exhibited significantly more positive lymph nodes than the non-tobacco group (P=0.04; Table II ).
In addition, among the 196 patients for whom information on stage and number of positive lymph nodes was available, Pearson's correlation found a positive correlation between the number of positive lymph nodes and the diagnostic stage of the tumor (r=0.48; P<0.001).
Finally, information pertaining to the number of positive lymph nodes and the NKR genotypes was available in 165 patients. Bartlett's χ 2 analysis showed that NK2R rs4644560 GC was associated with significantly more positive lymph nodes than rs4644560 CC (mean, 2.2 vs. 1.3; P=0.016; Table III) . Furthermore, the one-way ANOVA highlighted the interaction between NK2R rs4644560 and NK1R rs10198644, and showed that the number of positive lymph nodes was increased significantly in the rs4644560 GC/rs10198644 GG group compared with the rs4644560 GG/rs10198644 GG group (mean, 2.2 vs. 0.9; P=0.04), as shown in Fig. 1 .
Discussion
Based on the identification of the role of NK pathway genes in the risk of CRC, the allele frequencies of SNPs in two selected subtypes of NK receptor, NK1R and NK2R, were investigated and their potential association with various clinical factors was analyzed. Notably, despite the limitation of the sample size, tobacco exposure, diagnostic stage and the selected NKR genotypes were all found to be significantly associated with the number of metastatic lymph nodes, which is well known to be one of the most important prognostic factors in CRC (14, 15) . SNPs in receptor-encoded genes can affect a number of aspects of receptor function (16) , and may also result in an increased susceptibility to disease or produce variable responses to therapeutic agents (17) . There are several novel gene polymorphisms, including those for interleukin-10, SDF1α and embryonic ectoderm development, which have been proven to be associated with lymph node metastasis in CRC (18, 19) .
It is well known that lifestyle factors, such as cigarette smoking and alcohol consumption, may contribute to the risk of cancer. In the present study, patients exposed to tobacco exhibited significantly more positive lymph nodes than those patients not exposed to tobacco; this result is consistent with the finding that tobacco exposure has a detrimental effect on CRC (20) . In agreement with a previously published study (21) , the present study also found that diagnostic stage was associated with the number of metastatic lymph nodes.
As aforementioned, metastatic lymph nodes may be associated with a variety of clinical factors, therefore, its potential correlation with NK receptor polymorphisms, and their mutual interactions, was worthy of investigation. A previous study has shown that the stimulation of NK2R leads to partial blunting of the enhanced stimulatory effects mediated by NK1R. By contrast, stimulatory hematopoietic cytokines upregulate NK1R expression and downregulate the constitutively expressed NK2R in bone marrow stroma (22) . In the present study, the role of NK2R rs4644560 GC in predicting lymph node metastasis was clarified based on the finding that this heterozygote is associated with more positive lymph nodes than the homozygote (CC) of NK2R rs4644560. Notably, despite the complexity of information on clinical interactions, the interactive model of NK2R and NK1R was also found to be useful. NK2R rs4644560 GC was associated with more positive lymph nodes than the corresponding GG genotype when combined with NK1R rs10198644 GG. Further research should be performed to elucidate the potential mechanism underlying this interaction.
Little has been known with regard to the mechanism of NK2R in CRC carcinogenesis. One study, however, began to shed light on this area. The study found that activation of NK2R in afferent neurons led to the protein kinase C (PKC)-induced phosphorylation of a certain gene (23) . PKCδ was known to negatively modulate the canonical Wnt pathway and cell proliferation in colon tumor cell lines (24) . Moreover, the connection between NK2R and PKC was confirmed by another study, which showed that stimulation of NK2R was not only linked to PKC activation, but that it was also associated with the activation of a multidrug resistance protein transporter in vivo (25) . Extensive reviews have also described the neuropeptide receptors as targets for the treatment and diagnosis of cancer (5) . Based on the present findings, one novel therapeutic strategy for colon cancer in the future may be the inhibition of the potential signaling pathways associated with certain NK receptor genotypes.
Pending further research to clarify the potential mechanism of the malignant inclination of the NK2R rs4644560 GC genotype or its combination with NK1R rs10198644 GG, the present study indicates that these genotypes may act as a promising prognostic marker, which may predict lymph node metastasis in CRC patients.
